Medical News

RSS

Fart blanket here to make marriages better!

A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it “this year's Snuggie”.

6 May 2010

Chicken nuggets rate not too good in nutritional value: consumer report

A product evaluation organization Consumer Reports recently analyzed 12 brands of chicken nuggets including brands like Market Pantry (from Target), Bell & Evans Breaded, Kirland Signature Disney (Costco), and Health Is Wealth.

6 May 2010

Australia’s first ever health policy for men

Prime Minister Kevin Rudd yesterday announced Australia’s first ever men’s health policy called the “National Male Health Policy”. He said in the announcement during a visit to the Whittlesea Men's Shed in Victoria, “They either think that they're invincible that they can just tough it out…'They don't like talking about it usually, and frankly, the problem with all that is it makes it really hard to deal with men's health problems before they become too serious.” He felt this move was long due. He added, “'It's a pretty important time that we do that, we're probably about 110 years late.”

6 May 2010

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Keryx Biopharmaceuticals, Inc. announced today the initiation of its short-term Phase 3 study of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

6 May 2010

Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million

Abraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financial results for the first quarter ended March 31, 2010.

6 May 2010

SCOLR Pharma grants RedHill worldwide rights to market and sell CDT-based ondansetron

SCOLR Pharma, Inc. today announced that it has executed a Licensing Agreement with RedHill Biopharma Ltd. an Israeli corporation, (RedHill), granting RedHill the worldwide rights to market and sell ondansetron tablet formulations based on SCOLR's proprietary extended delivery technology (CDT). Ondansetron hydrochloride is the active ingredient in Zofran®, GlaxoSmithKline's drug to prevent chemotherapy and radiation related nausea and vomiting.

6 May 2010

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.

6 May 2010

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified the BYDUREON™ (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.

6 May 2010

Affymax reduces net loss to $7.9 million for first-quarter 2010

Affymax, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the first quarter of 2010 was $7.9 million compared to a net loss of $21.7 million for the first quarter of 2009.

6 May 2010

Advocates: Nonprofit hospitals too quiet about charity care

Kaiser Health News: Two advocate groups say hospitals make it too difficult for patients to find out whether they are eligible for free or discounted care. Access Project and Community Catalyst, the two groups, released the results of a small, 99-hospital survey Wednesday. The American Hospital Association contends that's too small to be meaningful, and that, at any rate, the issues it raises have been addressed in the health overhaul.

6 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Teleflex Medical voluntarily recalls certain lots of AQUA+FLEX Hygroscopic Condenser Humidifier

Teleflex Medical has announced a worldwide voluntary recall initiated on March 19, 2010, affecting certain lot numbers of the Teleflex Medical AQUA+FLEX Hygroscopic Condenser Humidifier (HCH) (catalog number 1570) a passive humidifier indicated for use to effectively warm and humidify inspired gas during mechanical ventilation.

6 May 2010

Curis reports net income of $4.8M for first-quarter 2010

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the first quarter ended March 31, 2010.

6 May 2010

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Columbia Laboratories, Inc. today announced financial results for the three-month period ended March 31, 2010.

6 May 2010

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).

6 May 2010

MOCON's net sales for first-quarter 2010 increase 15% to $7,093,000

MOCON, Inc. today reported its operating results for the quarter ended March 31, 2010.

6 May 2010

Cytori's first-quarter total revenues increase to $4.4 million

Cytori Therapeutics is reporting its first quarter financial results.

6 May 2010

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

PurGenesis Technologies Inc. announced today positive results from a Phase I clinical trial on PUR0110, the Company's lead investigational new drug for the treatment of ulcerative colitis. This successful trial was designed to evaluate the safety and maximum tolerated dose of PUR0110.

6 May 2010

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

6 May 2010

Public need to be informed of nanotechnology's risks as well as benefits: Survey

A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology's risks as well as its benefits - at least among those people who have heard of nanotechnology.

6 May 2010

Medical News

Fart blanket here to make marriages better!

Chicken nuggets rate not too good in nutritional value: consumer report

Australia’s first ever health policy for men

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million

SCOLR Pharma grants RedHill worldwide rights to market and sell CDT-based ondansetron

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

Affymax reduces net loss to $7.9 million for first-quarter 2010

Advocates: Nonprofit hospitals too quiet about charity care

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

Teleflex Medical voluntarily recalls certain lots of AQUA+FLEX Hygroscopic Condenser Humidifier

Curis reports net income of $4.8M for first-quarter 2010

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

MOCON's net sales for first-quarter 2010 increase 15% to $7,093,000

Cytori's first-quarter total revenues increase to $4.4 million

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

Public need to be informed of nanotechnology's risks as well as benefits: Survey

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News